XOMA Corp (XOMA)
25.80
-0.29
(-1.11%)
USD |
NASDAQ |
Apr 24, 11:07
XOMA Debt to Equity Ratio: 1.398 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 1.398 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.2307 |
December 31, 2020 | 0.2413 |
September 30, 2020 | 0.7873 |
June 30, 2020 | 0.8098 |
March 31, 2020 | 0.7668 |
December 31, 2019 | 0.7338 |
September 30, 2019 | 1.267 |
June 30, 2019 | 1.240 |
March 31, 2019 | 0.9398 |
December 31, 2018 | 1.197 |
September 30, 2018 | 19.11 |
June 30, 2018 | 3.061 |
March 31, 2018 | 2.585 |
December 31, 2017 | 2.518 |
Date | Value |
---|---|
September 30, 2017 | 3.525 |
June 30, 2017 | -0.9569 |
March 31, 2017 | -0.8532 |
December 31, 2016 | -0.9144 |
September 30, 2016 | -1.450 |
June 30, 2016 | -2.276 |
March 31, 2016 | -6.144 |
December 31, 2015 | -21.08 |
September 30, 2015 | -1.664 |
June 30, 2015 | -1.534 |
March 31, 2015 | -3.526 |
December 31, 2014 | 11.39 |
September 30, 2014 | -2.018 |
June 30, 2014 | -5.058 |
March 31, 2014 | 22.27 |
December 31, 2013 | -10.28 |
September 30, 2013 | -3.029 |
June 30, 2013 | -2.429 |
March 31, 2013 | -45.22 |
December 31, 2012 | 1.912 |
September 30, 2012 | -1.972 |
June 30, 2012 | 9.183 |
March 31, 2012 | 1.866 |
December 31, 2011 | 2.420 |
September 30, 2011 | 1.230 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
1.398
Maximum
Dec 2023
0.3934
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
Kinnate Biopharma Inc (DELISTED) | -- |
Societal CDMO Inc (DELISTED) | 0.6323 |
Corcept Therapeutics Inc | 0.00 |
Sarepta Therapeutics Inc | 1.441 |
AbbVie Inc | 5.732 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 234.30M |
Total Liabilities (Quarterly) | 145.58M |
Shareholders Equity (Quarterly) | 88.72M |
Current Ratio | 8.683 |
Net Debt Paydown Yield | -11.67% |